Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Genes
Original Article Clinical
Microbiote
MORTALITY
Biomarker
Safety
Gene methylation
Acceptability
IL12
Inhibitor
Stricture
Biologics
Immunosuppressant
Surgery
Disease progression
Eligibility
Ustekinumab
MARKER
18 FDG-PET/CT
Fecal microbiota
Crohn's disease
PCR
Microbiota
IBD
MALT
Inflammatory bowel diseases
HIV
Anti-TNF agents
Dysbiosis
Eradication
Epigenetics
Disability
Kidney diseases
Ulcerative colitis
Gènes
Screening
Crohn’s disease
Helicobacter pylori
Neoadjuvant chemotherapy
Inflammatory Bowel Diseases
Inflammatory bowel disease
Rituximab plus chlorambucil
Gene expression
Alkylating agents
Effectiveness
Monitoring
Vedolizumab
Patients experience
Cancer
Contraindication
Colonic epithelial primary cells
Intestinal crypts
Tuberculosis
Primary sclerosing cholangitis
DNA methylation
Over 80s
Algorithm
Cost effectiveness
RISK
Dysbiose
Inclusion
Colectomy
Bactéries
DNA METHYLATION
Bacteria
Venous thromboembolism
Maintenance therapy
Anti-TNF
Parvimonas micra
Colorectal cancer Colibactin and lipids
Immune cells
Rituximab
COLON-CANCER
Methylation
IL23
Disease Progression
Survival
Colon cancer
Epigénétiques
Colorectal cancer
Tailored therapy
Résistance
Cell adhesion
Endoscopic treatment
Thérapie ciblée
Small molecules
Clinical guidelines
Heart disease risk factors
Upper gastrointestinal tract
Consensus
Méthylation
Resistance
Colon
CARCINOGENESIS
Therapeutics
Patient-reported outcome
Clinical trial
MICROBIOTA
Drug
T1118 translocation
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|